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Abstract
Background: The receptor for advanced glycation endproducts, RAGE, is involved in the pathogenesis of many
inflammatory conditions, which is mostly related to its strong activation of NF-B but also due to its function as
ligand for the b2-integrin Mac-1. To further dissect the stimulus-dependent role of RAGE on leukocyte recruitment
during inflammation, we investigated b2-integrin-dependent leukocyte adhesion in RAGE
-/- and Icam1
-/- mice in
different cremaster muscle models of inflammation using intravital microscopy.
Results: We demonstrate that RAGE, but not ICAM-1 substantially contributes to N-formyl-methionyl-leucyl-
phenylalanine (fMLP)-induced leukocyte adhesion in TNF-a-pretreated cremaster muscle venules in a Mac-1-
dependent manner. In contrast, fMLP-stimulated leukocyte adhesion in unstimulated cremaster muscle venules is
independent of RAGE, but dependent on ICAM-1 and its interaction with LFA-1. Furthermore, chemokine CXCL1-
stimulated leukocyte adhesion in surgically prepared cremaster muscle venules was independent of RAGE but
strongly dependent on ICAM-1 and LFA-1 suggesting a differential and stimulus-dependent regulation of leukocyte
adhesion during inflammation in vivo.
Conclusion: Our results demonstrate that RAGE and ICAM-1 differentially regulate leukocyte adhesion in vivo in a
stimulus-dependent manner.
Background
Leukocyte recruitment into inflamed tissue is considered
a fundamental part of the inflammatory process and
therefore plays a crucial role in immune defence. Leuko-
cyte recruitment follows a well-defined cascade of
events, beginning with the capture of free-flowing leuko-
cytes to the vessel wall, followed by rolling, integrin-
mediated firm adhesion to the endothelial layer, postarr-
est modifications and finally transmigration into tissue
[1]. Firm adhesion of leukocytes to the endothelium cru-
cially depends on the b2-integrins LFA-1 (CD11a/CD18,
aLb2) and Mac-1 (CD11b/CD18, aMb2)w h i c hi n t e r a c t
with different endothelial ligands such as ICAM-1 and
RAGE, the receptor for advanced glycation end products
[1-4]. Deficiency of the b2-integrin CD18, an essential
part of both b2-integrins LFA-1 and Mac-1, leads to
severe recurrent acute and chronic infections in mice
and humans, which is caused by impaired leukocyte
adhesion [5-7]. Interestingly, deficiency of either LFA-1
or Mac-1 in mice only mildly affects leukocyte recruit-
ment in vivo indicating overlapping functions of LFA-1
and Mac-1 in mediating firm leukocyte adhesion [3,8].
Similarly, Icam1 knockout mice show only marginal
inflammatory defects [9]. Recently, we demonstrated in
a model of acute trauma-induced inflammation in the
mouse, that the concomitant absence of ICAM-1 and
RAGE leads to a dramatic decrease in leukocyte adhe-
sion when compared to control mice or mice where
only ICAM-1 or RAGE is absent [3]. These findings
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RAGE exert overlapping functions [3]. At present it is
unclear, if the adhesion molecules RAGE and ICAM-1
cooperate in a similar fashion in other models of inflam-
mation. This prompted us to further dissect the role of
ICAM-1 and RAGE for firm leukocyte adhesion under
different inflammatory conditions. Using intravital
microscopy, we observed leukocyte adhesion in cremas-
ter muscle venules of RAGE and Icam1 knockout mice
during trauma- or TNF-a-induced inflammation and
additional local stimulation with the leukocyte chemoat-
tractant peptide N-formyl-methionyl-leucyl-phenylala-
nine (fMLP) or systemic injection of the chemokine
CXCL1. Our findings expand previous reports in as
much as they show that besides its overlapping function,
ICAM-1 and RAGE also exhibit distinct and stimulus-
dependent functions in mediating leukocyte adhesion in
vivo.
Results
Leukocyte adhesion in trauma-induced inflammation
During trauma-induced inflammation, which is induced
by surgical preparation, firm leukocyte arrest is mostly
mediated via the b2-integrins LFA-1 and Mac-1 interact-
ing with ICAM-1 and RAGE, respectively [3]. Here, we
observed leukocyte adhesion in postcapillary venules of
the surgically prepared cremaster muscle of wild type,
RAGE
-/- and Icam1
-/- mice before and during fMLP
superfusion. Microvascular and hemodynamic para-
meters were similar between genotypes and treatment
groups and there were no significant changes of sys-
temic leukocyte counts during fMLP superfusion (Table
1). In line with an earlier report [3], leukocyte adhesion
in trauma-stimulated cremaster muscle venules was
similar in wild type mice, Icam1
-/- mice and RAGE
-/-
mice prior to fMLP superfusion (Figure 1). To explore
the contribution of RAGE and ICAM-1 in mediating
firm leukocyte adhesion in response to fMLP, we
observed leukocyte adhesion in postcapillary venules of
Table 1 Hemodynamic and microvascular parameters in cremaster muscle venules during trauma induced
inflammation and additional fMLP stimulation
Mice Venules Diameter Centerline
Velocity
Wall shear
rate
Systemic
leukocyte counts
(N) (n) (μm) (μm/s) (s-1) (cells/μl)
Wild type 10 13 33 ± 1 2700 ± 200 2000 ± 100 6600 ± 600
RAGE
-/- 6 10 33 ± 2 2700 ± 200 2100 ± 100 6800 ± 900
Icam1
-/- 4 4 30 ± 2 2400 ± 300 2000 ± 300 6400 ± 300
Wild type+ anti-Mac-1 6 19 30 ± 1 2500 ± 100 2100 ± 100 4800 ± 200
RAGE-
/-+ anti-Mac-1 4 14 29 ± 2 2500 ± 100 2100 ± 150 6700 ± 600
Wild type+ isotype AB 3 9 33 ± 2 2300 ± 100 1800 ± 100 6300 ± 700
Wild type+ anti-LFA-1 5 16 27 ± 1 2400 ± 100 2200 ± 100 6900 ± 700
RAGE-/-+ anti-LFA-1 6 20 30 ± 1 2400 ± 100 2200 ± 100 7900 ± 700
Wild type+ isotype AB 3 9 29 ± 2 2400 ± 100 2200 ± 200 5300 ± 400
n.s. n.s. n.s. n.s.
Vessel diameter, centerline velocity, wall shear rate and systemic leukocyte counts are presented as mean ± SEM of the investigated venules during trauma-
induced inflammation with additional local fMLP superfusion. N.s. = non significant.
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Figure 1 Leukocyte adhesion in trauma-induced inflammation
of cremaster muscle venules during additional fMLP
superfusion. Leukocytes adhesion (number of adherent cells/mm
2)
was observed in trauma-stimulated cremaster muscle venules of
wild type (WT) control mice (13 venules in 10 mice), RAGE
-/- mice(10
venules in 6 mice) and Icam1
-/- mice (4 venules in 4 mice) before
and during 5 minutes fMLP-superfusion (10 μM). All values are
presented as mean ± SEM and significant differences (p < 0.05) vs.
WT control mice are indicated by the asterisk.
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fMLP produced a strong increase in leukocyte adhesion
in both RAGE
-/- mice and wild type mice. In contrast,
fMLP-stimulated leukocyte adhesion was significantly
attenuated in Icam1
-/- mice suggesting that fMLP-
induced leukocyte adhesion in surgically prepared cre-
master muscle venules is dependent on ICAM-1, but
independent of RAGE (Figure 1).
Role of Mac-1 and LFA-1 for leukocyte adhesion in fMLP-
stimulated trauma-induced inflammation
To further dissect the role of b2-integrins for fMLP-sti-
mulated leukocyte adhesion, we investigated fMLP-
induced leukocyte adhesion in exteriorized cremaster
muscle venules of wild type and RAGE
-/- mice pre-
treated with blocking mAbs against the b2-integrins
M a c - 1o rL F A - 1u s i n ga n t iM a c - 1m A bT i b 1 2 8( c l o n e
M1/70) and anti LFA-1 mAb Tib217 (clone M17/4),
respectively. To rule out unspecific effects of the antibo-
dies we injected wild type mice with respective isotype
control antibodies. It is important to mention, that we
injected all antibodies immediately before fMLP superfu-
sion to identify the role of b2-integrins for fMLP
induced leukocyte adhesion only. Hemodynamic and
microvascular parameters did not vary significantly
between the different groups (Table 1). Before fMLP
superfusion leukocyte adhesion was similar in trauma-
stimulated cremaster muscle venules of wild type mice
and RAGE
-/- mice in response to different antibody
treatment (Figure 2). This is an expected finding due to
the fact that antibodies were injected after induction of
trauma. The fMLP-induced increase of leukocyte adhe-
sion (five minutes after fMLP) in wild type or RAGE
-/-
mice was not affected by pretreatment with Mac-1-
blocking mAbTib128. However, fMLP-induced leuko-
cyte adhesion was almost absent in wild type mice or
RAGE
-/- mice pretreated with LFA-1-blocking mAb
Tib217 (Figure 2) suggesting that fMLP-stimulated
adhesion is dependent on LFA-1 and ICAM-1 but inde-
pendent of RAGE and Mac-1.
Leukocyte adhesion in TNF-a-induced inflammation
Leukocyte adhesion in TNF-a-stimulated cremaster
muscle venules was observed by intravital microscopy in
six wild type mice, five RAGE
-/- mice, and four Icam1
-/-
mice. Hemodynamic and microvascular parameters did
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Figure 2 Role of Mac-1 and LFA-1 for leukocyte adhesion in surgically prepared cremaster muscle venules before and after additional
fMLP superfusion. Leukocytes adhesion (number of adherent cells/mm
2) is shown before and 5 minutes after fMLP-superfusion (10 μM) in
surgically prepared cremaster muscle venules of wild type mice (13 venules in 10 mice) and RAGE
-/- mice (10 venules in 6 mice) without
antibody treatment and after they were systemically treated with blocking antibodies against murine Mac-1 (Tib128; 19 venules in 6 wild type
mice and 14 venules in 4 RAGE
-/- mice) or LFA-1 (Tib217, 16 venules in 5 wild type mice and 20 venules in 6 RAGE
-/- mice), or their respective
isotype control antibodies (IgG2b for Mac-1; 11 venules in 4 wild type mice and IgG2a for LFA-1; 12 venules in 4 wild type mice) immediately
before starting fMLP superfusion. All values are presented as mean ± SEM and significant differences (p < 0.05) vs. control mice are indicated by
the asterisk.
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(Table 2). As described earlier, leukocyte adhesion was
significantly reduced in RAGE
-/- mice compared to wild
type mice or Icam1
-/- mice prior to fMLP superfusion
(Figure 3). Since fMLP is known to trigger leukocyte
adhesion in TNF-a-induced inflammation independent
of ICAM-1 [10], we wanted to test if fMLP-induced leu-
kocyte adhesion in TNF-a-treated cremaster muscle
venules is dependent on RAGE. Similar to the report by
Foy and Ley [10], we observed an increase in leukocyte
adhesion during five minutes of fMLP-superfusion in
TNF-a-treated cremaster muscle venules of Icam1
-/-
mice and wild type mice. However, there was no fMLP-
induced increase in leukocyte adhesion in RAGE
-/- mice
(Figure 3), suggesting that leukocyte adhesion is inde-
pendent of ICAM-1, but dependent on RAGE in this
setting.
Role of Mac-1 and LFA-1 for fMLP-induced leukocyte
adhesion in TNF-a-stimulated-cremaster muscle venules
To further explore the adhesion molecules involved in
fMLP-induced leukocyte adhesion of TNF-a-stimulated
cremaster muscle venules, we investigated fMLP-
induced leukocyte adhesion in TNF-a-treated cremaster
muscle venules using blocking mAbs against Mac-1 and
LFA-1. To rule out unspecific effects of the antibodies,
we injected wild type mice with respective isotype con-
trol antibodies. In parallel to the trauma model, we
injected all antibodies immediately before fMLP superfu-
sion to identify the role of b2-integrins for fMLP-
induced leukocyte adhesion only. Hemodynamic and
microvascular parameters were similar between the dif-
ferent groups (Table 2). As expected in this setting,
before fMLP superfusion leukocyte adhesion was similar
in TNF-a-stimulated cremaster muscle venules of wild
type mice and Icam1
-/- mice in the different treatment
groups (Figure 4). Five minutes after fMLP superfusion
the fMLP-induced increase of leukocyte adhesion was
absent in wild type treated with the Mac-1-blocking
mAb Tib128 shortly before fMLP superfusion (Figure
4). In contrast, in wild type mice treatment with LFA-1-
blocking antibody Tib217 did not alter fMLP-induced
leukocyte adhesion compared to wild type mice without
antibody treatment, suggesting that fMLP-induced leu-
kocyte adhesion in this setting is mostly dependent on
Mac-1 but not LFA-1. Accordingly, treatment of
Icam1
-/- mice with Mac-1-blocking mAb Tib128 abol-
ished fMLP-triggered leukocyte adhesion, while the
absence of ICAM-1 (with or without blockade of LFA-
1) did not influence the fMLP-induced increase in leu-
kocyte adhesion (Figure 4). These findings suggest that
fMLP-induced leukocyte adhesion in TNF-a-treated cre-
master muscle venules is dependent on RAGE and Mac-
1, whereas ICAM-1 and LFA-1 are not required.
Leukocyte adhesion following systemic stimulation by
chemokine CXCL1 in trauma-induced inflammation
To investigate a potential role of RAGE, ICAM-1 or LFA-
1 in chemokine-induced firm leukocyte arrest in vivo, we
systemically injected the CXCR2 chemokine CXCL1 (KC)
into RAGE
-/- and Icam1
-/- mice, and into wild type mice
with and without anti-LFA-1-blocking or isotype control
Table 2 Hemodynamic and microvascular parameters in cremaster muscle venules during TNF-a-induced inflammation
Mice Venules Diameter Centerline
Velocity
Wall shear
rate
Systemic
leukocyte counts
(N) (n) (μm) (μm/s) (s
-1) (cells/μl)
Wild type 6 6 30 ± 3 2200 ± 200 1800 ± 100 6300 ± 1000
RAGE
-/- 5 5 32 ± 2 2800 ± 200 2200 ± 200 4200 ± 700
Icam1
-/- 4 4 30 ± 2 2400 ± 300 2000 ± 300 6400 ± 300
Wild type +
anti-Mac-1
4 20 29 ± 2 2200 ± 100 2000 ± 100 4200 ± 200
Icam1
-/- +
anti-Mac-1
3 13 30 ± 2 2500 ± 100 2000 ± 100 4800 ± 400
Wild type + isotype 3 10 30 ± 2 2500 ± 100 2100 ± 100 4000 ± 500
Wild type +
anti-LFA-1
4 13 28 ± 2 2400 ± 100 2100 ± 100 4900 ± 300
Icam1
-/- +
anti-LFA-1
3 14 27 ± 3 2200 ± 200 2400 ± 400 5000 ± 300
Wild type + isotype 3 9 31 ± 2 2500 ± 100 2100 ± 200 4600 ± 300
n.s. n.s. n.s. n.s.
Vessel diameter, centerline velocity, wall shear rate and systemic leukocyte counts are presented as mean ± SEM of the investigated venules during TNF-a-
induced inflammation with additional local fMLP superfusion and after anti-Mac-1 and anti-LFA-1 antibody treatment. n.s. = non significant.
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been shown to induce firm leukocyte adhesion in exterior-
ized cremaster muscle venules of wild type mice [11,12].
Hemodynamic and microvascular parameters were similar
between the different groups (Table 3). Following systemic
injection of CXCL1, we observed a significant increase in
the number of adherent cells in wild type mice (Figure 5,
p < 0.05). Similarly, in RAGE-deficient mice the number of
adherent cells significantly increased five minutes after
CXCL1 injection (Figure 5, p < 0.05), suggesting that
CXCL-1-triggered activation of b2-integrins leading to
firm leukocyte arrest does not require RAGE. In contrast,
in Icam1
-/- mice, systemic injection of CXCL1 did not lead
to an increase in leukocyte adhesion (Figure 5) indicating
that CXCL1-triggered leukocyte arrest is strongly depen-
dent on ICAM-1. Furthermore, pretreatment of wild type
mice with the anti-LFA-1-blocking antibody Tib 217, but
not its isotype control antibody, inhibited CXCL1-induced
leukocyte arrest, suggesting that LFA-1 and ICAM-1 play
a predominant role in mediating CXCL1-triggered leuko-
cyte arrest during trauma-induced inflammation in vivo.
Stimulus-dependent expression of adhesion molecules in
cremaster muscle venules
Next, we addressed the question whether the stimulus-
dependent role of ICAM-1-LFA vs. RAGE-Mac-1 for
leukocyte adhesion is due to altered endothelial
expression of adhesion molecules. Immunohistochemis-
try was used to assess endothelial expression of ICAM-1
and RAGE in postcapillary venules of cremaster muscles
obtained from wild type mice either directly postmor-
tem (unstimulated), after exteriorization and superfusion
(trauma model) or after 3 h of TNF-a-stimulation fol-
lowed by surgical preparation (TNF-a model). While we
found no RAGE expression on the endothelium of
unstimulated cremaster muscle venules of wild type
mice (Figure 6A), after trauma and even more pro-
nounced during TNF-a-induced inflammation, RAGE
expression could be clearly detected (Figure 6C and 6E,
respectively). As illustrated in Figure 6B, D, F, we found
endothelial surface expression of ICAM-1 in unstimu-
lated, trauma- and TNF-a stimulated cremaster muscle
venules.
Beside representative micrographs, the immunostain-
ing were scored semi-quantitatively to compare
endothelial expression of RAGE to ICAM-1 between the
inflammatory models (Figure 6G). During trauma-
induced inflammation we found a moderate expression
of RAGE, which was slightly below that of ICAM-1
resulting in a RAGE/ICAM-1 expression ratio of 0.89.
TNF-a-stimulation produced a significant upregulation
of both RAGE and ICAM-1 compared to trauma-
induced inflammation. However, the increase of RAGE
expression was stronger than for ICAM-1, which is
reflected by a RAGE/ICAM-1 expression ratio of 1.06
indicating that expression of RAGE is more strongly
inducible by inflammatory stimulation than expression
of ICAM-1.
Stimulus-dependent expression of LFA-1 and Mac-1
To further explore underlying mechanisms, we investi-
gated Mac-1 and LFA-1 expression on isolated wild type
neutrophils pretreated with TNF-a, fMLP, or CXCL1
using flow cytometry. LFA-1 expression on wild type
neutrophils was strongly upregulated after fMLP and
CXCL-1 treatment compared to baseline expression
(Figure 7A). However, neutrophils pretreated with TNF-
a followed by fMLP treatment only showed a mild
increase in LFA-1 expression (Figure 7A). In contrast,
expression of Mac-1 was only mildly increased in
response to fMLP or CXCL-1,b u ti n c r e a s e ds t r o n g l y
upon stimulation with TNF-a and fMLP when com-
pared to unstimulated neutrophils (Figure 7B). These
results demonstrate that LFA-1 and Mac-1 expression
are differentially affected by the various stimuli which is
in line with the in vivo results shown in Figure 2 and 4.
Discussion
The receptor of advanced glycation endproducts RAGE
belongs to the pattern recognition receptors and exerts
its central function during acute and chronic
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Figure 3 Leukocyte adhesion in TNF-a-stimulated cremaster
muscle venules during additional fMLP superfusion. Leukocytes
adhesion (number of adherent cells/mm
2) was observed in 3 h TNF-
a-stimulated cremaster muscle venules of wild type (WT) control
mice (6 venules in 6 mice), RAGE
-/- mice (5 venules in 5 mice) and
Icam1
-/- mice (4 venules in 4 mice) before and during 5 minutes
fMLP-superfusion (10 μM). All values are presented as mean ± SEM
and significant differences (p < 0.05) vs. WT control mice are
indicated by the asterisk.
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Page 5 of 12inflammations not only as a strong activator of the
proinflammatory transcription factor NF-Bb u ta l s oa s
endothelial-expressed ligand for the b2-integrin Mac-1
[3,4,13]. The biological relevance of RAGE as a ligand
for Mac-1 has been recently demonstrated in RAGE
-/- ×
Icam1
-/- mice where leukocyte adhesion was almost
completely absent in an acute surgically-induced model
of inflammation in the cremaster muscle in vivo [3] sug-
gesting that RAGE and ICAM-1 cooperate closely in
mediating firm leukocyte adhesion, with RAGE interact-
ing with Mac-1 and ICAM-1 binding to LFA-1. Interest-
ingly, the same study revealed that under circumstances
where inflammation was induced by local treatment
with TNF-a plus the surgical trauma, leukocyte
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Figure 4 Role of Mac-1 and LFA-1 for leukocyte adhesion in TNF-a-stimulated cremaster muscle venules before and after additional
fMLP superfusion. Leukocytes adhesion (number of adherent cells/mm
2) is shown before and 5 minutes after fMLP-superfusion (10 μM) in 3 h
TNF-a-stimulated cremaster muscle venules of wild type control mice and Icam1
-/- mice, which are systemically treated with blocking antibodies
against murine Mac-1 (Tib128; 20 venules in 4 wild type mice and 13 venules in 3 Icam1
-/- mice), LFA-1 (Tib217, 13 venules in 4 wild type mice
and 14 venules in 3 Icam1
-/- mice) or their respective isotype control antibodies (IgG2b for Mac-1; 10 venules in 3 wild type mice and IgG2a for
LFA-1; 8 venules in 3 wild type mice) immediately before starting fMLP superfusion or without antibody pretreatment (6 venules in 6 wild type
mice and 4 venules in 4 Icam1
-/- mice). All values are presented as mean ± SEM and significant differences (p < 0.05) vs. WT control mice and
Icam1
-/- control mice are indicated by the asterisk.
Table 3 Hemodynamic and microvascular parameters in cremaster muscle venules during trauma induced
inflammation with additional CXCL1 stimulation
Mice Venules Diameter Centerline
Velocity
Wall shear
rate
Systemic
leukocyte counts
(N) (n) (μm) (μm/s) (s-1) (cells/μl)
Wild type 7 12 32 ± 3 2200 ± 300 1600 ± 200 6300 ± 500
RAGE
-/- 6 10 32 ± 3 2000 ± 200 1800 ± 200 7400 ± 800
Icam-1
-/- 4 11 28 ± 1 2400 ± 100 2100 ± 100 8000 ± 800
Wild type+
anti-LFA-1
4 10 28 ± 2 2400 ± 100 2200 ± 100 7000 ± 500
Wild type+
Isotype AB
3 9 29 ± 2 2500 ± 200 2200 ± 100 7500 ± 600
n.s. n.s. n.s. n.s.
Vessel diameter, centerline velocity, wall shear rate and systemic leukocyte counts are presented as mean ± SEM of the investigated venules during trauma-
induced inflammation and systemic injection of the chemokine CXCL1 (KC). N.s. = non significant.
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RAGE and ICAM-1 suggesting that alternative, yet
unknown integrin ligands exist and that the close
cooperation of RAGE and ICAM-1 as b2-integrin
ligands is stimulus-dependent (Table 4) [3]. To further
investigate the role of RAGE as Mac-1 ligand during
leukocyte recruitment, we studied here leukocyte
adhesion in cremaster muscles of RAGE
-/-,I c a m 1
-/-
and wild type mice using different inflammatory mod-
els in the cremaster muscle. We show that additional
fMLP stimulation during trauma-induced inflamma-
tion leads to increased leukocyte adhesion which is
independent of RAGE but dependent on ICAM-1,
while fMLP superfusion in TNF-a pretreated cremas-
ter muscle venules induces RAGE-dependent adhesion
which was independent of ICAM-1 (Table 4). Addi-
tional studies using mAbs against Mac-1 and LFA-1
confirmed that RAGE interacts with Mac-1 and
ICAM-1 with LFA-1, respectively. These findings
imply that the same pro-inflammatory agent (i.e.
fMLP) can lead to different biological effects. This is
also supported by an earlier report from Foy and Ley
[10] showing that fMLP-induced leukocyte adhesion
in vivo is only dependent on ICAM-1 in exteriorized
cremaster muscles without any other stimulus while
additional prestimulation with TNF-a leads to an
ICAM-1-independent increase in leukocyte adhesion
following fMLP superfusion [10]. The molecular
mechanisms responsible for the differential and stimu-
lus-dependent regulation of b2-integrin-mediated leu-
kocyte adhesion are currently unclear.
On the endothelial side, our immunohistochemical
findings showed a stimulus-dependent expression of
ICAM-1 and RAGE. During trauma-induced inflamma-
tion, endothelial RAGE expression was less than ICAM-
1 expression, while after TNF-a treatment RAGE
expression on the inflamed endothelium was slightly
higher than ICAM-1 expression. However, these subtle
differences in expression might not explain, why fMLP-
induced leukocyte adhesion relies on LFA-1/ICAM-1
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Figure 5 Leukocyte adhesion in CXCL1-stimulated cremaster muscle venules. The number of adherent cells (mean ± SEM) was assessed in
exteriorized cremaster muscle venules of RAGE
-/- mice (10 venules in 6 mice), Icam1
-/- mice (11 venules in 5 mice), untreated (12 venules in 7
mice), anti-LFA-1 antibody (10 venules in 4 mice) or isotype antibody (9 venules in 3 mice) treated wild type mice before and five minutes after
systemic injection of CXCL1 (keratinocyte-derived chemokine, KC; 600 ng/mouse). Significant differences (p < 0.05) of the number of adherent
leukocytes before CXCL1 vs. after injection of CXCL1 are indicated by *, # and § for wild type mice, RAGE
-/- mice and isotype antibody treated
wild type mice, respectively.
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Figure 6 Stimulus-dependent expression of RAGE and ICAM-1 in cremaster muscle venules. Immunostaining was conducted to assess
endothelial expression of RAGE (A, C, E) and ICAM-1 (B, D, F) in postcapillary venules of cremaster muscles obtained directly postmortem
(Unstimulated, upper panel), after exteriorization and 20 min superfusion (Trauma, middle panel), or after 3 h of TNF-a-stimulation and following
exteriorization (TNF-a, lower panel; at least 3 mice/group). Application of primary antibody was performed i.v. before harvesting the cremaster
muscle in order to stain RAGE and ICAM-1 on the endothelial surface. Biotinylated secondary antibody, peroxidase-conjugated streptavidin and
diaminobenzidine (DAB) were used to detect endothelial expression of ICAM-1 and RAGE as brown signal. Counter-staining was performed by
Mayer’s hemalaun. Reference bar for the representative images is shown in A and represents 20 μm. Intensity of venular anti-RAGE and anti-
ICAM-1 immunostaining during trauma- and TNF-a-induced inflammation were analyzed semiquantitatively and presented as mean ± SEM (G; 0
= no, 1 = weak, 2 = medium, 3 = strong signal). Significant differences (p < 0.05) of TNF-a-induced RAGE or ICAM-1 expression vs. trauma are
indicated by the asterisk or the pound key, respectively. Relative ratios of expression of RAGE to ICAM-1 are quantified for the trauma and TNF-a
model as illustrated.
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RAGE during TNF-a-stimulated inflammation.
In contrast, our flow cytometric analysis on the
expression of Mac-1 and LFA-1 showed that LFA-1
expression on wild type neutrophils was profoundly
increased after CXCL1 or fMLP treatment, while pre-
treatment with TNF-a followed by fMLP did not alter
LFA-1 expression. Inversely, Mac-1 upregulation was
most prominent on TNF-a plus fMLP treated neutro-
phils in comparison to CXCL1 or fMLP treatment
alone. These findings are in line with our in vivo find-
i n g sa n da l s ot op r e v i o u so b s e r v a t i o n ss h o w i n gt h a t
TNF-a induces Mac-1, but not LFA-1 expression on
neutrophils [14,15].
Besides these more quantitative changes in the
expression of Mac-1 and LFA-1 on PMN, additional
mechanisms could lie in qualitative changes, i.e. in a
stimulus-dependent activation of b2-integrins differing
between Mac-1 and LFA-1 [16]. Our group recently
showed that ICAM-1 binding to LFA-1 (but not to
Mac-1) mediates firm leukocyte adhesion in inflamed
cremaster muscle venules, whereas leukocyte crawling
in the same setting is dependent on interactions
between ICAM-1 and Mac-1 [3]. This suggests that
during firm leukocyte arrest, different activation signals
are necessary to enable interactions between LFA-1
and ICAM-1 or Mac-1 and ICAM-1. Indeed, different
mechanisms of Mac-1 and LFA-1 activation are
reported. Fagerholm and colleagues found that ICAM-
1 binding to Mac-1 in neutrophils is regulated by a-
chain phosphorylation of Mac-1 [17,18]. As Chatila et
al. demonstrated in an earlier study that fMLP treat-
ment of unstimulated PMN did not affect a-chain
phosphorylation of Mac-1 [19], this might explain why
Mac-1 does not significantly contribute to fMLP-trig-
gered adhesion during trauma-induced inflammation.
Noteworthy, LFA-1 and Mac-1 also differ in their
binding site on ICAM-1. While LFA-1 uses the D3
domain on ICAM-1 for binding, Mac-1 recognizes the
D5 domain on ICAM-1 [20,21].
Finally, posttranslational glycosylation has been
reported as an important regulatory mechanism for leu-
kocyte arrest and integrin-dependent adhesion [22]. For
the b2-integrin Mac-1, Feng et al. demonstrated recently
that activation of endogenous PMN sialidase leads to
desialylation of Mac-1 with a subsequent increase in
leukocyte adhesion [23]. The authors explained their
findings by a better exposure of the activation epitope
on Mac-1 upon desialylation of crucial sialic acid resi-
dues on Mac-1.
Conclusions
Our study provides evidence that RAGE is a relevant,
but context-dependent Mac-1 ligand during inflamma-
tion in vivo. In addition, the presented findings expand
our view of the complex and stimulus-dependent regula-
tion of leukocyte adhesion during inflammation
(depicted in Table 4), which might lead to new RAGE-
based strategies to specifically interfere with the recruit-
ment of immune cells during specific acute and chronic
inflammatory conditions.
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Figure 7 Stimulus-dependent expression of LFA-1 and Mac-1
on neutrophils. Surface expression of LFA-1 (A) and Mac-1 (B) on
bone marrow-derived neutrophils (n = 3 mice) after stimulation
with CXCL1 (KC; 120 ng per 10
6 leukocytes/ml, 15 min), fMLP (10
μM, 10
6 leukocytes/ml, 15 min), or TNF-a+ fMLP (25 ng TNF-a for 3
h followed by 10 μM fMLP for 15 min in 10
6 leukocytes/ml) was
compared to unstimulated controls (B). Representative histograms
are shown from 3 separate experiments.
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Animals
RAGE
-/- mice and Icam1
-/- mice were generated as
described earlier and backcrossed for at least seven gen-
erations into the C57BL/6 background [24,25]. All mice
were maintained as breeding colonies at the Central
Animal Facility of the University of Heidelberg, Ger-
many. The animal experiments were approved by the
Animal Care and Use Committee of the Regierungsprä-
sidium Karlsruhe, Germany (AZ 35-9185.81/G-67/03
and AZ 35-9185.81/G-08/08).
Antibodies and cytokines
In some intravital microscopic experiments, fMLP (10
μM; Sigma, Seisenhofen, Germany) was added to the
superfusion buffer to induce additional leukocyte adhe-
sion as described [26]. In certain experiments, recombi-
nant murine TNF-a (R&D) was injected intrascrotally at
a dose of 500 ng per mouse 3 hours before intravital
microscopy. In some experiments, recombinant murine
CXCR2 chemokine CXCL1 (keratinocyte-derived che-
mokine KC; Peprotech, London, UK) was injected sys-
temically at a dose of 600n g / m o u s e .B l o c k i n g
antibodies against murine Mac-1 (Tib128, clone M1/70,
rat IgG2b) and murine LFA-1 (Tib217, clone M17/4, rat
IgG2a) were obtained from American Type Culture Col-
lection (ATCC, Manasses, USA) and systemically admi-
nistered at 100 μg/mouse immediately before starting
fMLP superfusion.
Intravital microscopy
Mice were prepared for intravital microscopy as
reported recently [12]. Briefly, mice were anesthetized
with intraperitoneal (i.p.) injection of ketamine (125 mg/
kg body weight, Ketanest
®, Pfizer GmBH, Karlsruhe,
Germany) and xylazine (12.5 mg/kg body weight; Rom-
pun
®, Bayer, Leverkusen, Germany) and placed on a
heating pad to maintain body temperature at 37°C.
Intravital microscopy was conducted on an upright
microscope (Leica; Wetzlar, Germany) with a saline
immersion objective (SW40/0.75 numerical aperture,
Zeiss, Jena, Germany). To ease breathing mice were
intubated using PE 90 tubing (Becton Dickinson and
Company, Sparks, MD, USA). The left carotid artery
was cannulated with PE 10 tubing (Becton Dickinson
and Company, Sparks, MD, USA) for blood sampling
and systemic mAb administration.
Cremaster muscle preparation
The surgical preparation of the cremaster muscle for
intravital microscopy was performed as previously
described [27]. Briefly, the scrotum was opened and the
cremaster muscle was mobilized. After longitudinal inci-
sion and spreading of the muscle over a cover glass, the
epididymis and testis were moved and pinned to the
side giving full microscopic access to the cremaster
muscle microcirculation. Cremaster muscle venules
were recorded via CCD camera (CF8/1; Kappa, Glei-
chen, Germany) on a Panasonic S-VHS recorder. The
cremaster muscle was superfused with thermocontrolled
(35°C) bicarbonate-buffered saline. For local treatment
with fMLP, 10 μM fMLP was added to the superfusion
buffer and administrated over 15 min to the cremaster
muscle tissue similar to a previously described protocol
[26]. Postcapillary venules under observation were
recorded before and during fMLP administration and
ranged from 20-40 μm in diameter. Systemic blood sam-
ples (10 μl) were taken and assessed for white blood cell
count before and after experiment. Blood samples were
diluted 1:10 with Türck’s solution (Merck, Darmstadt,
Germany) and leukocytes concentration was expressed
as number of leukocytes per microliter of whole blood
using hematocytometer. Microvascular parameters
(venular diameter, venular vessel segment length) were
measured using an image processing system [28,29].
Venular centerline red blood cell velocity was measured
during the experiment via a dual photodiode and a digi-
tal on-line cross-correlation program (Circusoft Instru-
mentation, Hockessin, USA). An empirical factor of
0.625 was used to convert centerline velocities to mean
blood flow velocities [30]. Wall shear rates (gw)w e r e
estimated as 4.9 (8vb/d), where vb is mean blood flow
velocity and d the diameter of the vessel [31,32].
Immunohistochemistry
To investigate the endothelial expression of RAGE and
ICAM-1 on unstimulated cremaster muscle venules,
during trauma- or TNF-a-induced inflammation, we
Table 4 Stimulus-dependent regulation of RAGE and ICAM-1-mediated firm leukocyte adhesion in inflamed
postcapillary venules of the cremaster muscle
Trauma-induced inflammation TNF-a-induced inflammation
Stimulation: None fMLP KC None fMLP
ICAM-1 - LFA-1 +
b +
a, c +
a -
b -
a, c
RAGE - Mac-1 +
b -
a -
a +
b +
a
Additional yet unknown integrin ligands -
b -
a -
a +
b -
a
a this study,
b reference [3],
c in part reference [10]
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mount cremaster muscles as described [3]. Briefly, pri-
mary antibodies against RAGE (polyclonal rat anti
mouse; 30 μg/mouse; Santa Cruz, Heidelberg, Germany)
or ICAM-1 (YN-1, monoclonal rat anti mouse; 30 μg/
mouse; ATCC) were systemically injected and incubated
for 10 min ensuring staining of RAGE and ICAM-1 on
the endothelial surface. Excess antibody was washed out
from the circulation with normal saline solution either
before scarifying the mouse (unstimulated) or after 20
min superfusion of the cremaster muscle (trauma- and
TNF-a-stimulation). Cremaster muscle whole mounts
were surgically prepared as reported previously [3] and
transferred onto adhesive slides (Superfrost; Menzel,
Germany). Staining of tissue samples for endothelial
ICAM-1 and RAGE expression was performed using
diaminobenzidine (DAB kit; Vector Lab, Burlingame,
USA). Analysis of stained slides was conducted semi-
quantitatively in a blinded manner (0 = no, 1 = weak, 2
= medium, 3 = strong signal) on a Leica DMRB upright
microscope and a ×25/0,75 NA oil immersion objective
(both Leica, Wetzlar, Germany). Photographs of the
samples were taken using a color CCD camera
(KAPPA).
Flow cytometry
The expression of Mac-1 and LFA-1 on bone marrow-
derived neutrophils was assessed by flow cytometry as
described previously [3]. After red blood cell lysis, 10
6
leukocytes/ml were stimulated for 15 min with 120 ng
CXCL1 (KC) or 10 μMf M L Pa l o n e ,o rw i t h2 5n g
TNF-a over 3 h followed by 10 μMf M L Pf o r1 5m i n
(all at 37°C). Next, cells were incubated in the dark with
FITC-conjugated anti- Mac-1 mAb M1/70 (1 μg/10
5
cells, rat IgG2b; eBioscience, San Diego, USA), FITC-
conjugated LFA-1 mAb M17/4 (1 μg/10
5 cells, rat
IgG2a; eBioscience, San Diego, USA) or respective
FITC-conjugated isotype control antibodies (1 μg/10
5
cells, rat IgG2b or rat IgG2a; eBioscience, San Diego,
USA) to detect anti-Mac-1 and LFA-1 signals, respec-
tively. Mac-1 and LFA-1 expression was assessed on
10.000 cells/mouse within the neutrophil cluster defined
by forward-side scatter analysis using LSRII with DIVA
software package (Becton Dickinson, San Jose, USA).
Expression of Mac-1 and LFA-1 upon stimulation with
fMLP, CXCL1, or TNF-a followed by fMLP was com-
pared to unstimulated cells and their respective isotype
controls.
Statistics
Sigma Stat 3.5 (Systat Software, Erkrath, Germany) was
used for statistical analysis. Leukocyte counts, vessel dia-
meters, centerline velocity, leukocyte adhesion and wall
shear rates were compared with one-way ANOVA
followed by a multiple pairwise comparison test (Dunn’s
test) or by Wilcoxon rank-sum test, as appropriate. Sta-
tistical significance was set at p < 0.05.
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